SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Hannover Rück SE (HVRRF) trades at a trailing P/E of 14.6, forward P/E of 11.9. Trailing earnings yield is 6.84%, forward earnings yield 8.40%. PEG 1.10.
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (14.6); earnings yield beats bond yields (6.84%).
- Forward P/E 11.9 (down from trailing 14.6) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.10 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 6.84% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 8.40% as earnings recover.
Overall SharesGrow Score: 83/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HVRRF
Valuation Multiples
P/E (TTM)14.6
Forward P/E11.9
PEG Ratio1.10
Forward PEG0.52
P/B Ratio0.00
P/S Ratio1.61
EV/EBITDA0.0
Per Share Data
EPS (TTM)$21.88
Forward EPS (Est.)$26.88
Book Value / Share$0.00
Revenue / Share$199.16
FCF / Share$0.00
Yields & Fair Value
Earnings Yield6.84%
Forward Earnings Yield8.40%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$9.71 |
$16.06B |
$1.17B |
7.3% |
| 2017 |
$7.95 |
$17.48B |
$958.56M |
5.5% |
| 2018 |
$8.79 |
$18.97B |
$1.06B |
5.6% |
| 2019 |
$10.65 |
$21.66B |
$1.28B |
5.9% |
| 2020 |
$7.32 |
$23.28B |
$883.07M |
3.8% |
| 2021 |
$10.21 |
$26.15B |
$1.23B |
4.7% |
| 2022 |
$11.66 |
$31.6B |
$1.41B |
4.5% |
| 2023 |
$15.13 |
$25.72B |
$1.82B |
7.1% |
| 2024 |
$19.31 |
$2.66B |
$2.33B |
87.7% |
| 2025 |
$21.88 |
$24.02B |
$2.64B |
11% |
